Stories for sharing and giving this Christmas
During the coming days many girls and boys are feeding the "tió" and leaving lists of wishes for Santa Claus or the Magic Kings - so we suggest two gifts that will also raise money to help others.
At the IGTP TODAY
News
A study of an atypical form of DM1 will improve the diagnosis and management of this rare disease
The Neuromuscular and Neuropediatric Group at the IGTP, led by Gisela Nogales-Gadea have identified a subset of patients with an atypical type of myotonic dystrophy type 1 (MD1), which develops later and with more severe symptoms than usual. This has important implications for diagnosis of these patients, who can be misdiagnosed or not given the correct prognosis. It is also vital for managing the disease correctly in patients and their families. The study has been published in Human Mutation.
- Research
The importance of COST Action Networks in increasing research collaborations for rare diseases
In the context of research and especially in the case of research into rare diseases, the COST Action Projects (Cooperation in Science and Technology) are key to fostering transnational cooperation. This is the message that a group of Spanish scientists, which includes Dr Gisela Nogales, have sent in a letter recently published in The Lancet Neurology.
The IGTP shares its research projects for European Researchers’ Night
For the first time the IGTP has participated in the European Researchers' Night, part of the European Commission's Horizon 2020 Programme, which aims bring scientists and society together. Five researchers from the institute have participated in science popularization events.
Two Can Ruti PhD students at the INPhNIT award ceremony
Two students have been awarded INPhINIT grants by “la Caixa” Foundation to complete their PhDs on the Can Ruti Campus. Emma Koehorst, has been working on Myotonic Dystrophy in the Neuromuscular and Neuropaediatric research group led by Gisela Nogales at the IGTP since last September. Ifeanyi Ezeonwumelu has started working at the IrsiCaixa on novel therapeutic strategies for HIV with Dr Ester Ballana Guix in the HIV Pathogenesis Group, led by Dr José A Esté.
- Research
The IGTP participates in the debates of the 11th Research Workshop of the ICS: childhood obesity and rare diseases
Experts in paediatric research agree on the need to anticipate and act on obesity from childhood. The importance of early interventions to prevent obesity and excess weight and research into rare diseases have been the main topics of the 11th Research Workshop of the Catalan Institute of Health (ICS), which took place at the Seminari de Tarragona (Centre Tarraconense).
Can Ruti shows it cares for rare diseases
The IGTP and the Germans Trias Hospital face the spotlight for rare diseases again. This year our professionals are joining World Rare Disease Day on the last day of February to highlight these diseases and shine a light on the research activities in the field on campus.
The Noa Warrior Princess initiative has collected 5,311 euros for research into rare paediatric diseases at the IGTP
This week Noa and her parents have visited the IGTP laboratories to present a symbolic cheque for the 5,311 euros raised to finance research into rare paediatric diseases by the IGTP Neuromuscular and Neuropaediatric Research Group. The money was collected at a charity football match on 12 October in the Municipality of Llefià.
- Research
New insights from a study of family members of patients with McArdle’s Disease
A study led by the Neuromuscular and Neuropediatric Research Group at the Germans Trias i Pujol Research Institute shows for the first time that carriers of McArdle's disease can also show symptoms.
- Research
Supervised exercise regimes drastically reduce symptoms for McArdle’s disease patients
The Neuromuscular and Neuropaediatrics Research Group at the IGTP particpates in the largest study of McArdle’s disease patients carried out in Spain. The study, published in BMC Genomics, concluded that the best therapy is to adopt a supervised exercise regime.
